The third red flag relates to the mindset revealed in the review's report—a mindset that questions and even belittles the industry's motives and drivers in its approach to health technology assessment. The industry has its own mindset challenge. …
The HTA Review report - 'Red Flag' number three of five
September 17, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Moderna announces positive Phase 3 result for influenza vaccine
July 1, 2025 - - Latest News -
Research lagging for sarcoma, despite accounting for one third of adolescent cancer deaths
July 1, 2025 - - Latest News -
Takeda therapy now available through the PBS for serious viral infection
July 1, 2025 - - Latest News -
The real question is why expectations were so high in the first place
July 1, 2025 - - Latest News -
National Pharmacies appoints experienced industry leader as new CEO
July 1, 2025 - - Latest News -
Tetratherix lists on the ASX following successful IPO
June 30, 2025 - - Australian Biotech -
LTR Pharma achieves key FDA milestone through extractables study
June 30, 2025 - - Australian Biotech